Watson David O. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Watson David O.
General Counsel
Transactions
- Sale
Common Stock
2025-09-16$24.34/sh−5,000$121,700→ 118,730 total
Holdings
- 50,136(indirect: By Trust)
Common Stock
- 10,000(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]This was a scheduled sale from 10B5-1 trading plan dated March 3, 2025.
- [F2]This represents a custodial account held by the reporting person for the sole benefit of his minor children.
- [F3]The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.